Novel augmentation therapy with cilostazol for the geriatric major depressive disorder patient with deep white matter hyperintensities on T2-weighted brain MRI: a case report.
Takahashi
K
K
Oshima
A
A
Inoue
K
K
Takeyoshi
H
H
Fukuda
M
M
Mikuni
M
M
D000368:Aged; D000928:Antidepressive Agents / Q000627:therapeutic use; D001921:Brain / Q000000981:diagnostic imaging / Q000187:drug effects / Q000473:pathology*; D000077407:Cilostazol; D003865:Major Depressive Disorder / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology*; D004357:Drug Synergism; D005260:Female; D005853:Geriatrics; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D009457:Neuroglia / Q000000981:diagnostic imaging / Q000187:drug effects*; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D013777:Tetrazoles / Q000627:therapeutic use*; D015899:Tomography, Emission-Computed, Single-Photon
D000928:Antidepressive Agents; D018696:Neuroprotective Agents; D013777:Tetrazoles; D000077407:Cilostazol